ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
June 10, 2019Combination therapy of PD-1/PD-L1 antibodies with multi-kinase inhibitors that target VEGFR can induce significant synergistic anti-tumour effects, demonstrating CS1001 immuno-oncology potential in patients suffering from gastric cancer and serious malign
Pharma Sources Insight January 2025
